SHELI WARD: Open Payments
NPI 1447634019 · HANCEVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 12 payments from 9 companies in 2025. Trend: 2023 $51 · 2024 $558 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $60 |
| Exact Sciences Corporation | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Lilly USA, LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, Cologuard Collection Kit, The Cologuard Plus Collection Kit, JARDIANCE, Ozempic, CONTRAVE, NURTEC ODT.
Industry payments across AL — which companies pay providers there.
